Newsroom

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (« Avanzanite »), une entreprise pharmaceutique spécialisée en pleine croissance et déjà active sur le plan commercial, dédiée à l’accès aux traitements des maladies rares pour les patients pour l’Europe, a annoncé aujourd’hui la signature d’un accord exclusif avec Agios Pharmaceuticals Inc. (Nasdaq : AGIO), une entreprise de biotechnologie basée à Boston, spécialisée dans le développement et la commercialisation de médicaments dans les mal...

LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti plc ("AngloGold Ashanti" or the "Company") has been named for the first time as a preliminary addition to the Russell 1000® or Russell 2000®, the Russell 3000®, and the Russell Midcap® Indexes, as part of the latest FTSE Russell 2025 U.S. Indexes reconstitution. Final index membership will become effective after the U.S. market closes on Friday, 27 June 2025, with rebalanced index constituents reflected in trading beginning Mond...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that it will host an Investor R&D Day in New York City and via webcast on June 26, 2025 at 8:30 am ET. John V. Oyler, Co-Founder, Chairman, and CEO of BeOne, along with the Company's leadership team and distinguished key opinion leaders, will provide an update on BeOne’s extensive global innovation pipeline and platforms, including new assets, targets...

LOS ANGELES--(BUSINESS WIRE)--Trinity Hunt Partners-backed Herringbone Digital, a digital marketing platform partnering with best-in-class local digital marketing agencies, service providers, and tech-enabled solutions, today announced the acquisition of Hennessey Digital, a leading digital marketing agency serving law firms nationwide. This strategic acquisition marks Herringbone Digital's first investment in the legal marketing vertical and expands upon its multi-industry strategy to build a...

CANTON, Mass.--(BUSINESS WIRE)--Baskin-Robbins® is coming to the rescue of parents everywhere with a new limited-time offer designed for the busiest—and possibly most chaotic—weeks of summer break. Introducing the Parent Pass: a scoop-sized sigh of relief for moms and dads who find themselves in survival mode when school’s out and camp hasn’t quite started yet. From June 16 through June 27, Monday through Friday only, the brand will exclusively offer Baskin-Robbins Rewards® members $1.99 scoops...

SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth, a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, announced it received United States Food and Drug Administration (FDA) approval for pediatric use of its groundbreaking SONU Band. SONU is the world’s first FDA De Novo authorized, AI-enabled, wearable medical device for at-home treatment of moderate to severe nasal congestion due to allergic and non-allergic rhinitis. This ex...

NEW YORK--(BUSINESS WIRE)--Franklin BSP Realty Trust, Inc. (NYSE: FBRT) (“FBRT” or the “Company”) today announced its Board of Directors has declared a second quarter 2025 dividend of $0.355 per common share. The dividend is payable on or about July 10, 2025 to common stockholders of record as of June 30, 2025. The Board of Directors also declared a second quarter 2025 dividend on its convertible Series H Preferred Stock in an amount equal to the as-converted common dividend amount. FBRT’s Boar...

NUREMBERG, Germany--(BUSINESS WIRE)--VIA optronics AG (OTC: VIAOY) (“VIA” or the “Company”), a leading supplier of interactive display solutions, today announced several updates related to its business transformation initiatives, 2024 and 2025 outlook, as well as a search for a new strategic investor. This update follows the release of audited financials for fiscal 2023 and the Company plans to file its fiscal 2024 financial results shortly. Key Highlights: VIA has made significant progress exe...